Latest News - Acquisitions and Mergers

Friday, September 21, 2018

Almirall Finalizes Acquisition of Allergan US Medical Dermatology Portfolio

Almirall, S.A. finalized its acquisition of products from Allergan's Medical Dermatology unit in the US: Aczone (dapsone), Tazorac (tazarotene), Azelex (azelaic acid), and Cordran Tape (flurandren…

Read the full story

Friday, September 14, 2018

Breaking Business News: Allergan Acquires Bonti

Allergan acquired Bonti, Inc., a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin programs for aesthetic and therap…

Read the full story

Tuesday, September 11, 2018

Business News: Candela Acquires Ellipse

Candela Corporation has acquired Ellipse, a Danish medical device company that manufactures and markets Intense Pulsed Light (IPL) and laser-based platforms for a wide variety of medical and aesthetic…

Read the full story

Wednesday, September 05, 2018

Canfield Scientific Acquires Leading German Dermoscopy Company VISIOMED AG

Canfield Scientific has acquired German company VISIOMED AG, which designs and manufactures dermoscopy systems. The resulting business has decades of experience in aesthetic documentation, 3D imaging,…

Read the full story

Friday, August 03, 2018

Almirall to Acquire Allergan’s US Medical Dermatology Unit

Almirall is acquiring a portfolio of five products from Allergan’s Medical Dermatology unit in the United States, conditional to the clearance by the relevant authorities. The portfolio includes…

Read the full story

Tuesday, July 31, 2018

LEO Pharma to Acquire Bayer Prescription Dermatology Business

LEO Pharma has entered into a definitive agreement to buy Bayer's global prescription dermatology unit. The portfolio to be acquired includes branded topical prescription treatments for acne, fung…

Read the full story

Monday, June 04, 2018

Gryphon Investors Makes Majority Investment in Water's Edge Dermatology

Gryphon Investors has made a majority investment in Water’s Edge Dermatology. Terms of the transaction were not disclosed. Gryphon Investors is a San Francisco-based middle market privat…

Read the full story

Friday, March 30, 2018

Escalier Biosciences Closes Financing, Focuses on Psoriasis

Escalier Biosciences BV, a privately held biopharmaceutical company, this month closed $19 million Series B financing. The round was led by Forbion with existing investors New Science Ventur…

Read the full story

Tuesday, November 14, 2017

Obagi Eyes the Future Under New Ownership

The sale of Obagi Medical Products to the Haitong International Zhonghua Finance Acquisition Fund I, L.P. and limited partners China Regenerative Medicine International (CRMI) Ltd. is now complete. …

Read the full story

Wednesday, November 08, 2017

Novan Plans to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution

Novan, Inc., has agreed in principle to a business structure that would enable further development and advancement of SB204 for the treatment of acne vulgaris via third party financing and third party…

Read the full story

Wednesday, August 02, 2017

Modernizing Medicine To Add More Than 800 Jobs in Expansion

Modernizing Medicine will expand operations and add a total of 838 jobs by 2022. The expansion, to be implemented in the historic Boca Raton Innovation Center (BRIC) in Palm Beach County will result i…

Read the full story

Tuesday, July 25, 2017

Histogen’s Growth Factor Technology Now Part of Allergan's Skin Care Line

Histogen’s growth factor technology will be marketed as part of Allergan's skin care line within its recently acquired Regenica® Advanced Rejuvenation System. The Regenica line is bas…

Read the full story

Tuesday, July 18, 2017

Valeant to Sell Obagi Medical Products Business for $190 M

Valeant Pharmaceuticals International, Inc. has entered into an agreement to sell its Obagi Medical Products business for $190 million in cash to Haitong International Zhonghua Finance Acqui…

Read the full story

Monday, July 17, 2017

Syneron Candela Completes Transaction with Funds Advised by Apax Partners; Becomes a Private Company

Syneron Medical Ltd. announced the successful completion of its acquisition by an affiliate of funds advised by Apax Partners for $11.00 per share in cash in a transaction valued at approximately $400…

Read the full story

Friday, April 28, 2017

Allergan Officially Adds Coolsculpting to Portfolio

It’s a done deal. Allergan now owns ZELTIQ® Aesthetics. Allergan acquired ZELTIQ® Aesthetics for approximately $2.4 billion in cash. ZELTIQ® stockholders approved the transa…

Read the full story
Load More